f.danquah
TL2 Moderator · Mysuru
Contributes reviews on supplier material. Based in Mysuru.
Joined 7 December 2024 · last posted 4h
94 posts, newest first. Showing up to 150.
-
How to ask about something you suspect is a bad idea — a second dataset Replied, post #3 · Start Here › How to Ask · 28 Jul 2026 · 15 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Follow-up: UK access routes, dated and sourced Replied, post #15 · Regional › UK & Ireland · 26 Jul 2026 · 10 likes On post #11 — agreed on the reasoning, with one qualification. Cross-border arrangements: some people source from other EU countries. Rules on import for personal use…
-
Why side effects reset at each escalation and that is not a failure Replied, post #7 · Practice › Side effects · 22 Jul 2026 · 23 likes Picking up post #4: that is the part I would want checked first. Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some…
-
How shortages have affected compounding permissions Replied, post #53 · Access › Shortages · 20 Jul 2026 · 0 likes Picking up post #50: that is the part I would want checked first. Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on…
-
[2026 update] Journal club: what we got wrong in an earlier session Replied, post #8 · Evidence › Journal club · 19 Jul 2026 · 7 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Seven-day rolling means and why weekly readings mislead Replied, post #53 · Outcomes › Progress reports · 18 Jul 2026 · 0 likes This follows post #50 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
What a certificate commits its issuer to Replied, post #50 · Analytics › COA interpretation · 17 Jul 2026 · 15 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #68 · Evidence › Journal club · 17 Jul 2026 · 14 likes I read post #66 twice before replying, because I had assumed the opposite. Session format: read the paper before posting. The discussion is much better when everyone…
-
About the Independent verification category Replied, post #3 · Sourcing › Independent verification · 16 Jul 2026 · 32 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Does a peptide degrade silently, with no visual change? Replied, post #70 · Practice › Storage & stability · 14 Jul 2026 · 2 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #96 · Evidence › Journal club · 10 Jul 2026 · 24 likes I read post #94 twice before replying, because I had assumed the opposite. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #25 · Analytics › Impurities & related substances · 26 Jun 2026 · 3 likes I read post #23 twice before replying, because I had assumed the opposite. Truncation products: fragments from incomplete synthesis or from degradation. They elute…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #126 · Practice › Reconstitution · 23 Jun 2026 · 7 likes This follows post #123 rather than contradicting it. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at…
-
Follow-up: Sleep quality changes during weight loss Replied, post #50 · Wellbeing › Sleep · 21 Jun 2026 · 7 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
Spreadsheets: an appreciation — what changed since Replied, post #76 · Lounge › Off topic · 20 Jun 2026 · 33 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #24 · Compounds › Secretagogues & GH axis · 16 Jun 2026 · 0 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #15 · Evidence › Meta-analyses · 13 Jun 2026 · 22 likes Coming back to post #13, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Revisiting: What pooling buys you and what it destroys Replied, post #51 · Evidence › Meta-analyses · 11 Jun 2026 · 0 likes On post #47 — agreed on the reasoning, with one qualification. Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by…
-
Racemisation and why it is invisible to a mass measurement Replied, post #39 · Analytics › Impurities & related substances · 10 Jun 2026 · 10 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Historical amylin analogues and what happened to them Replied, post #16 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2026 · 9 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
GLP-1 receptor distribution: central and peripheral Replied, post #63 · Pharmacology › Receptor biology · 5 Jun 2026 · 17 likes post #62 is right about the mechanism and I think understates the practical bit. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through…
-
Carryover and the ghost peak from last week's standard — what changed since Started this topic · Analytics › HPLC & UHPLC · 1 Jun 2026 · 16 likes Carryover and the ghost peak from last week's standard — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Posting…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #32 · Analytics › HPLC & UHPLC · 25 May 2026 · 0 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Reading a home test result without over-claiming Replied, post #20 · Analytics › Home & field testing · 23 Apr 2026 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #22 · Clinical › Bloodwork · 16 Apr 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #9 · Compounds › Oral incretins · 15 Apr 2026 · 9 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #37 · Practice › Administration · 29 Mar 2026 · 0 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #56 · Lounge › Introductions · 13 Mar 2026 · 6 likes This follows post #53 rather than contradicting it. What to include: your name or handle, how you found the community, what brings you here, maybe something about…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #15 · Meta › Announcements · 12 Mar 2026 · 0 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #34 · Practice › Administration · 5 Mar 2026 · 11 likes Coming back to post #32, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Coming back to: Time to steady state after a dose increase Replied, post #7 · Pharmacology › Pharmacokinetics · 28 Feb 2026 · 5 likes Coming back to post #5, because the follow-up matters more than the original answer. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino)…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #112 · Practice › Dosing & titration · 21 Feb 2026 · 1 like This follows post #109 rather than contradicting it. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #18 · Clinical › Comorbidities · 11 Feb 2026 · 14 likes Worth separating two things that post #14 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #24 · Compounds › Semaglutide · 10 Feb 2026 · 0 likes post #23 is right about the mechanism and I think understates the practical bit. The STEP programme populations were selected: enrollment criteria required baseline…
-
Guidelines revision: what changed and why — one year on Replied, post #65 · Meta › Announcements · 1 Feb 2026 · 0 likes post #64 is right about the mechanism and I think understates the practical bit. Scheduled maintenance: if the site is going offline for maintenance, advance notice…
-
Trifluoroacetate content and its consequences Replied, post #47 · Analytics › Impurities & related substances · 30 Jan 2026 · 3 likes Coming back to post #45, because the follow-up matters more than the original answer. Incomplete deprotection: mass higher by the protecting group mass. Usually…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #140 · Documentation › Doc review · 26 Jan 2026 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What a stability-indicating method is and how you demonstrate one Replied, post #5 · Analytics › Method validation · 25 Jan 2026 · 27 likes This follows post #2 rather than contradicting it. Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by…
-
Follow-up: Search filters: what is missing Replied, post #18 · Meta › Site feedback · 21 Jan 2026 · 19 likes This follows post #15 rather than contradicting it. Feature requests: if the site would work better with a feature it does not have (better search, different filtering,…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #2 · Practice › Storage & stability · 20 Dec 2025 · 19 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #28 · Research Methods › N-of-1 designs · 17 Dec 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Sleep quality changes during weight loss — what changed since Replied, post #65 · Wellbeing › Sleep · 16 Nov 2025 · 0 likes On post #61 — agreed on the reasoning, with one qualification. Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during…
-
[2026 update] What steady state means for the decision to escalate Replied, post #69 · Practice › Dosing & titration · 12 Nov 2025 · 1 like I read post #67 twice before replying, because I had assumed the opposite. The four-week escalation interval is a convention from the pivotal trials, not a…
-
Titles that describe the question, not the situation Replied, post #144 · Start Here › How to Ask · 9 Nov 2025 · 0 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #13 · Devices › Pens & autoinjectors · 5 Nov 2025 · 15 likes Injection duration: most pens deliver the dose over several seconds. Holding the button down for the full duration ensures complete delivery. Releasing early can result…
-
Reading SURMOUNT-1 without the press release Replied, post #52 · Compounds › Tirzepatide · 1 Nov 2025 · 0 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #55 · Compounds › Tirzepatide · 25 Oct 2025 · 0 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #29 · Practice › Interactions · 9 Oct 2025 · 2 likes Picking up post #26: that is the part I would want checked first. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk.…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #5 · Safety › Adverse events · 8 Oct 2025 · 5 likes This follows post #2 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #107 · Compounds › Oral incretins · 23 Sep 2025 · 0 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
A comparison of home results against a laboratory result on the same vial Replied, post #40 · Analytics › Home & field testing · 23 Sep 2025 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #39 · Evidence › Journal club · 22 Sep 2025 · 0 likes Worth separating two things that post #35 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #97 · Data & Tools › Datasets · 10 Sep 2025 · 26 likes post #96 answers the question as asked. The question underneath it is different. Temporal bias: older data in a dataset might reflect conditions (supplier, formulation,…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #39 · Analytics › COA interpretation · 31 Aug 2025 · 0 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #34 · Analytics › Mass spectrometry · 17 Jul 2025 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #89 · Wellbeing › Mental health · 14 Jul 2025 · 31 likes This follows post #86 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Substitution between formats during a shortage Replied, post #20 · Access › Shortages · 9 Jul 2025 · 0 likes post #19 is right about the mechanism and I think understates the practical bit. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are…
-
[2026 update] Heterogeneity as information rather than as a nuisance Replied, post #4 · Evidence › Meta-analyses · 8 Jul 2025 · 1 like Picking up the opening post: that is the part I would want checked first. Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #122 · Clinical › Comorbidities · 22 Jun 2025 · 5 likes post #121 is right about the mechanism and I think understates the practical bit. Chronic kidney disease: compounds in this class have renal benefit in people with…
-
Regression to the mean in progress reports Replied, post #20 · Research Methods › Statistics · 13 Jun 2025 · 9 likes Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #24 · Sourcing › Regulatory · 13 Jun 2025 · 11 likes Coming back to post #22, because the follow-up matters more than the original answer. Regulatory positions change: a compound's status today might differ from its…
-
Counter-ion content and its effect on measured mass Replied, post #57 · Analytics › Mass spectrometry · 6 Jun 2025 · 21 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Half-life, steady state, and accumulation worked through Replied, post #14 · Pharmacology › Pharmacokinetics · 23 May 2025 · 1 like Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Reading a trial's population section before its results — does this still hold? Replied, post #131 · Evidence › Trials · 22 May 2025 · 22 likes Worth separating two things that post #127 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #38 · Regional › UK & Ireland · 18 May 2025 · 0 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Telehealth prescribing models in the US Replied, post #85 · Regional › North America · 16 Apr 2025 · 10 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
Reading an MS report that only gives you a single number Replied, post #53 · Analytics › Mass spectrometry · 15 Apr 2025 · 1 like I read post #51 twice before replying, because I had assumed the opposite. Mass accuracy is expressed in parts per million. It is the difference between observed and…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #15 · Evidence › Journal club · 12 Apr 2025 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #65 · Compounds › Semaglutide · 5 Apr 2025 · 11 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #11 · Sourcing › Vendor reports · 21 Mar 2025 · 28 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
UK access routes, dated and sourced — a second dataset Replied, post #51 · Regional › UK & Ireland · 16 Mar 2025 · 14 likes Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines…
-
Scheduled maintenance and what will be unavailable Replied, post #67 · Meta › Announcements · 9 Mar 2025 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #74 · Evidence › Journal club · 9 Mar 2025 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Criticising the method without criticising the authors Replied, post #42 · Evidence › Study critique · 24 Feb 2025 · 29 likes This follows post #39 rather than contradicting it. What makes a methodological criticism substantive: it identifies a specific feature of the design that materially…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #44 · Compounds › Secretagogues & GH axis · 16 Feb 2025 · 8 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
-
A supplier that answers analytical questions with restated claims Replied, post #22 · Sourcing › Red flags · 10 Feb 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What we do not know about retatrutide, listed explicitly Replied, post #83 · Compounds › Retatrutide · 5 Feb 2025 · 0 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Protein density versus volume when you cannot eat much Replied, post #43 · Nutrition & Training › Protein & intake · 31 Jan 2025 · 13 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
When to suspect the method rather than the sample Replied, post #69 · Analytics › Method validation · 21 Jan 2025 · 12 likes This follows post #66 rather than contradicting it. Range: the concentration range over which the method has been validated. Going outside the validated range is going…
-
A certificate whose chromatogram axes do not match its stated method Replied, post #3 · Sourcing › Red flags · 20 Jan 2025 · 0 likes Picking up post #2: that is the part I would want checked first. Documentation quality as a signal: a supplier that reports method identifiers, distinguishes…
-
Recovery when intake is low: what to cut first Replied, post #65 · Nutrition & Training › Resistance training · 13 Jan 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #20 · Practice › Interactions · 7 Jan 2025 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: When to suspect the method rather than the sample Replied, post #101 · Analytics › Method validation · 20 Dec 2024 · 0 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Body image changing more slowly than the body Replied, post #65 · Wellbeing › Mental health · 18 Dec 2024 · 0 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #75 · Access › Insurance & coverage · 18 Dec 2024 · 1 like This follows post #72 rather than contradicting it. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #67 · Compounds › Tirzepatide · 29 Nov 2024 · 8 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Fixed versus detachable needles: the trade-offs Replied, post #19 · Devices › Syringes & needles · 25 Nov 2024 · 3 likes I read post #17 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #13 · Clinical › Special populations · 20 Nov 2024 · 0 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
EMA product information as a primary source — does this still hold? Replied, post #65 · Regional › European Union · 16 Nov 2024 · 16 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #25 · Compounds › Semaglutide · 14 Nov 2024 · 30 likes Picking up post #22: that is the part I would want checked first. The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear.…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #6 · marked as the solution · Practice › Dosing & titration · 7 Nov 2024 · 12 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #14 · Sourcing › Regulatory · 26 Oct 2024 · 6 likes On post #10 — agreed on the reasoning, with one qualification. Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy…
-
Reporting a discrepancy without making an allegation Replied, post #45 · Sourcing › Vendor reports · 27 Aug 2024 · 5 likes Picking up post #42: that is the part I would want checked first. Structured report format: compound, lot, independent testing service, method as reported, result, and…
-
[2026 update] Request: show the solution author in the topic list Replied, post #2 · Meta › Feature requests · 5 Jul 2024 · 0 likes Tracking: staff will update the status of feature requests (under consideration, planned, implemented, declined). Checking back lets you know the fate of your suggestion.